Byoung Dae Lee

Kyung Hee University — South Korea

Medicine · Health Sciences

16h-index2.2kcitations23works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(12), Protein Kinase Regulation and GTPase Signaling(4), PARP inhibition in cancer therapy(4), Receptor Mechanisms and Signaling(3), Neuroscience and Neuropharmacology Research(2)

Publications23 total

Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease
Molecular Neurodegeneration·2025Open Access
LC3B drives transcription-associated homologous recombination via direct interaction with R-loops
Nucleic Acids Research·2024· 4 citedOpen Access
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Proceedings of the National Academy of Sciences·2018· 97 citedOpen Access
Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
eNeuro·2017· 38 citedOpen Access
Erratum: Corrigendum: Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss
Nature Neuroscience·2015· 8 citedOpen Access
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
Proceedings of the National Academy of Sciences·2015· 241 citedOpen Access
Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor
PLoS ONE·2014· 13 citedOpen Access
Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
BMB Reports·2014· 48 citedOpen Access
Ribosomal Protein s15 Phosphorylation Mediates LRRK2 Neurodegeneration in Parkinson’s Disease
Cell·2014· 267 citedOpen Access
Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss
Nature Neuroscience·2013· 213 citedOpen Access
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
Trends in Pharmacological Sciences·2012· 75 citedOpen Access
Measuring the Activity of Leucine-Rich Repeat Kinase 2: A Kinase Involved in Parkinson’s Disease
Methods in molecular biology·2011· 3 citedOpen Access
Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage
Proceedings of the National Academy of Sciences·2011· 261 citedOpen Access
Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
ACS Chemical Biology·2011· 149 citedOpen Access
Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
Human Molecular Genetics·2011· 134 citedOpen Access
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Nature Medicine·2010· 381 citedOpen Access
Pituitary Adenylate Cyclase-Activating Polypeptide 27 Is a Functional Ligand for Formyl Peptide Receptor-Like 1
The Journal of Immunology·2006· 27 citedOpen Access
Epidermal Growth Factor Increases Insulin Secretion through Phospholipase D2 activation
The FASEB Journal·2006
Leumorphin has an anti‐apoptotic effect by activating epidermal growth factor receptor kinase in rat pheochromocytoma PC12 cells
Journal of Neurochemistry·2005· 5 cited
Sensitization of Epidermal Growth Factor-induced Signaling by Bradykinin Is Mediated by c-Src
Journal of Biological Chemistry·2004· 72 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Valina L. Dawson(12), Ted M. Dawson(12), Ho Chul Kang(8), Joo‐Ho Shin(7), Yunjong Lee(7), Sung Ho Ryu(7), Han Seok Ko(6), Yun-Il Lee(6), Haisong Jiang(4), Sung-Ung Kang(4), Senthilkumar S. Karuppagounder(4), Lino Tessarollo(4), Jeannette N. Stankowski(3), Shaida A. Andrabi(3), Yulan Xiong(3), Debbie Swing(3), Jae Ho Kim(3), Sang Do Lee(3), Yong Kim(3), Pann‐Ghill Suh(3)